Viewing Study NCT01682434


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2025-12-27 @ 11:31 PM
Study NCT ID: NCT01682434
Status: WITHDRAWN
Last Update Posted: 2014-05-02
First Post: 2012-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Wavefront-guided LASIK for Correction of Myopia
Sponsor: Aarhus University Hospital
Organization:

Study Overview

Official Title: Wavefront-guided LASIK for Correction of Myopia
Status: WITHDRAWN
Status Verified Date: 2014-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Institution changed surgical method to small-incision lenticule extraction. Study never started.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Laser in situ keratomileusis is a successful procedure for the treatment of low to moderate myopia.

Advances over the last decade have allowed LASIK to also correct higher order wavefront aberrations. In low myopia, there seem to be a minor effect of such wavefront-guided treatment. However, it remains to be established whether there is a beneficial effect in higher degrees of myopia.

The study aims to determine whether myopic subjects (-6 to -10 diopters) with higher-than-average preoperative higher-order aberrations have benefit of wavefront-guided treatment. Subjects are randomized to wavefront-guided treatment in one eye, and conventional treatment in the other.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: